Table 4: Multivariate analysis of LRC, DFS and OS. Significant parameters are highlighted in bold.
|
|
LRC |
DFS |
OS |
|||
|
Variable |
HR (95% CI) |
p-value |
HR (95% CI) |
p-value |
HR (95% CI) |
p-value |
|
Age <50 vs 50-59 |
0.68 (0.23, 1.99) |
0.48 |
0.61 (0.25, 1.49) |
0.28 |
0.57 (0.22, 1.48) |
0.25 |
|
Age <50 vs 60-69 |
0.60 (0.18, 2.01) |
0.41 |
0.56 (0.23, 1.36) |
0.20 |
0.64 (0.24, 1.69) |
0.37 |
|
Age <50 vs 70 |
0.67 (0.22, 2.02) |
0.47 |
1.00 (0.44, 2.28) |
>0.99 |
1.68 (0.70, 3.99) |
0.24 |
|
Clinical T Stage cT1-2 vs cT3-4 |
1.36 (0.64, 2.88) |
0.42 |
1.21 (0.71, 2.07) |
0.48 |
1.70 (0.95, 3.04) |
0.072 |
|
p16 Status negative vs positive |
0.25 (0.10, 0.68) |
0.006 |
0.25 (0.13, 0.49) |
<0.001 |
0.25 (0.12, 0.52) |
<0.001 |
|
CD44 Score <163 vs 163+ |
2.78 (1.16, 6.65) |
0.022 |
1.86 (1.00, 3.47) |
0.050 |
2.15 (1.11, 4.15) |
0.023 |
|
c-MET Score <187 vs 187+ |
2.10 (0.91, 4.84) |
0.082 |
1.41 (0.78, 2.53) |
0.26 |
1.91 (1.02, 3.57) |
0.044 |
|
MTOR Score <86 vs 86+ |
1.37 (0.55, 3.44) |
0.50 |
1.54 (0.80, 2.97) |
0.20 |
1.25 (0.61, 2.57) |
0.54 |
|
EGFR Score <32 vs 32+ |
2.07 (0.83, 5.14) |
0.12 |
1.95 (1.05, 3.60) |
0.034 |
2.19 (1.12, 4.28) |
0.022 |
|
GLUT1 Score <187 vs 202+ |
0.51 (0.18, 1.45) |
0.21 |
0.56 (0.26, 1.19) |
0.13 |
0.61 (0.28, 1.30) |
0.20 |
|
GLUT1 <187 vs unknown |
0.78 (0.21, 2.87) |
0.70 |
0.89 (0.35, 2.27) |
0.81 |
1.22 (0.46, 3.22) |
0.69 |